Skip to main content
Advertisement

< Back to Article

Mutational signature dynamics indicate SARS-CoV-2’s evolutionary capacity is driven by host antiviral molecules

Fig 3

Mutational signatures extracted from the SARS-CoV-2 genome sequences by non-negative matrix factorisation.

Signatures are patterns of probabilities for each category of substitution in a three nucleotide context. Each bar represents a context and is coloured by the substitution category of the mutation that occurs there. Each signature may represent a distinct mutational process. Signature 1 is heavily biased towards cytosine to thymine (C→T) mutations, particularly in 3’ CpG contexts TCG, CCG and ACG. Signature 2 from SARS-CoV-2 is predominantly adenine to guanine (A→G), guanine to adenine (G→A) and thymine to cytosine mutations (T→C). Signature 3 is strongly guanine to thymine (G→T), a pattern that is thought to be caused by the action of guanine oxidation by reactive oxygen species. Signatures are shown normalised against the tri-nucleotide composition of the SARS-CoV-2 genome. Non-normalised forms in the context of the SARS-CoV-2 genome composition are shown in S5 Fig.

Fig 3

doi: https://doi.org/10.1371/journal.pcbi.1011795.g003